EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 270 filers reported holding EXELIXIS INC in Q3 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $184,000 | -16.0% | 11,704 | +11.1% | 0.01% | +16.7% |
| Q2 2022 | $219,000 | +397.7% | 10,530 | +315.5% | 0.01% | +100.0% |
| Q1 2020 | $44,000 | +1000.0% | 2,534 | +1167.0% | 0.00% | – |
| Q4 2019 | $4,000 | -97.5% | 200 | -97.0% | 0.00% | -100.0% |
| Q1 2019 | $159,000 | +3080.0% | 6,680 | +2126.7% | 0.01% | – |
| Q3 2018 | $5,000 | -89.8% | 300 | -86.8% | 0.00% | -100.0% |
| Q2 2018 | $49,000 | +2.1% | 2,272 | +3.8% | 0.00% | 0.0% |
| Q1 2018 | $48,000 | -62.2% | 2,189 | -47.7% | 0.00% | -70.0% |
| Q4 2017 | $127,000 | +176.1% | 4,187 | +120.0% | 0.01% | +150.0% |
| Q3 2017 | $46,000 | +39.4% | 1,903 | +26.9% | 0.00% | +33.3% |
| Q1 2017 | $33,000 | +266.7% | 1,500 | +114.3% | 0.00% | +200.0% |
| Q3 2016 | $9,000 | -76.3% | 700 | -93.0% | 0.00% | -80.0% |
| Q2 2015 | $38,000 | – | 10,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
| Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
| CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
| Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
| Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
| Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
| Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |